Stock listing

Abl Diagnostics Sa

Selected listing: A3DL82 · LS · EUR · DE

Abl Diagnostics Sa (Lang & Schwarz: A3DL82), Finance. Latest release Oct 1, 2026: ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million…

A3DL82:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3DL82
Asset type: Stock
Sector: Finance
Industry: Financial Conglomerates
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Abl Diagnostics Sa

ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million - €14.0 Million

October 1, 2026

ABL TEXCELL DIAGNOSTICS RELÈVE SON OBJECTIF DE CHIFFRE D’AFFAIRES 2026 À UNE FOURCHETTE DE 13,5 M€ À 14,0 M€

September 30, 2026

ABL Texcell Diagnostics: Availability of the 2026 Half-Year Financial Report

September 30, 2026

ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United States

September 21, 2026

ABL Diagnostics Becomes ABL Texcell Diagnostics

September 17, 2026

All Abl Diagnostics Sa news →

Research Abl Diagnostics Sa

Abl Diagnostics Sa company profile

View the public company page for Abl Diagnostics Sa on 6ix.

Abl Diagnostics Sa news

Read company news and market updates connected to Abl Diagnostics Sa.

Abl Diagnostics Sa investor events

Find investor webinars, events, and replay context for Abl Diagnostics Sa.